

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.33533845 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.33533845 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.07682845 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.07682845 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.67592687 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.30755248 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.09331519 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.09331519 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.09331519 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.93828042 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.88338489 |
| 12 | epoxygenase P450 pathway (GO:0019373) | 5.74131398 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.72111210 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.64849099 |
| 15 | cysteine metabolic process (GO:0006534) | 5.52979058 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.45267760 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.38483044 |
| 18 | urea metabolic process (GO:0019627) | 5.36965594 |
| 19 | urea cycle (GO:0000050) | 5.36965594 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.31559749 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.18658611 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 5.09839489 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.98474637 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.97926106 |
| 25 | protein carboxylation (GO:0018214) | 4.97926106 |
| 26 | regulation of fibrinolysis (GO:0051917) | 4.97499951 |
| 27 | regulation of cholesterol esterification (GO:0010872) | 4.96732415 |
| 28 | lysine catabolic process (GO:0006554) | 4.96084652 |
| 29 | lysine metabolic process (GO:0006553) | 4.96084652 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.95311329 |
| 31 | bile acid metabolic process (GO:0008206) | 4.88672670 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 4.86530146 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.85629819 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.84606515 |
| 35 | regulation of protein activation cascade (GO:2000257) | 4.80386322 |
| 36 | complement activation, alternative pathway (GO:0006957) | 4.79932596 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.76971620 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.74322607 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.74322607 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.74322607 |
| 41 | phospholipid efflux (GO:0033700) | 4.66469262 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.66341878 |
| 43 | negative regulation of sterol transport (GO:0032372) | 4.62406720 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 4.62406720 |
| 45 | cellular ketone body metabolic process (GO:0046950) | 4.57307689 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 4.56670559 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.56182345 |
| 48 | regulation of complement activation (GO:0030449) | 4.47911670 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.46930755 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.46930755 |
| 51 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.39972592 |
| 52 | drug catabolic process (GO:0042737) | 4.38577837 |
| 53 | bile acid and bile salt transport (GO:0015721) | 4.35431081 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 4.30964522 |
| 55 | glutamate metabolic process (GO:0006536) | 4.29403126 |
| 56 | cellular glucuronidation (GO:0052695) | 4.27537980 |
| 57 | blood coagulation, intrinsic pathway (GO:0007597) | 4.26376598 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 4.25919415 |
| 59 | amine catabolic process (GO:0009310) | 4.22075773 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 4.22075773 |
| 61 | serine family amino acid metabolic process (GO:0009069) | 4.21859230 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 4.21710644 |
| 63 | coenzyme catabolic process (GO:0009109) | 4.21031436 |
| 64 | cellular modified amino acid catabolic process (GO:0042219) | 4.20439264 |
| 65 | protein-lipid complex subunit organization (GO:0071825) | 4.18326140 |
| 66 | glycine metabolic process (GO:0006544) | 4.16924049 |
| 67 | omega-hydroxylase P450 pathway (GO:0097267) | 4.15967177 |
| 68 | cholesterol efflux (GO:0033344) | 4.13540706 |
| 69 | drug metabolic process (GO:0017144) | 4.12002537 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 4.11081748 |
| 71 | plasma lipoprotein particle assembly (GO:0034377) | 4.02333662 |
| 72 | serine family amino acid biosynthetic process (GO:0009070) | 4.01662214 |
| 73 | drug transmembrane transport (GO:0006855) | 4.01583212 |
| 74 | acute-phase response (GO:0006953) | 4.00267557 |
| 75 | ethanol oxidation (GO:0006069) | 3.98185652 |
| 76 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.96442619 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 3.96054440 |
| 78 | ketone body metabolic process (GO:1902224) | 3.95636469 |
| 79 | urate metabolic process (GO:0046415) | 3.95285277 |
| 80 | low-density lipoprotein particle remodeling (GO:0034374) | 3.94179562 |
| 81 | angiotensin maturation (GO:0002003) | 3.93649576 |
| 82 | arginine metabolic process (GO:0006525) | 3.92611661 |
| 83 | short-chain fatty acid metabolic process (GO:0046459) | 3.92361525 |
| 84 | aldehyde catabolic process (GO:0046185) | 3.90777776 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.89756233 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.89756233 |
| 87 | protein activation cascade (GO:0072376) | 3.85931202 |
| 88 | uronic acid metabolic process (GO:0006063) | 3.85625535 |
| 89 | glucuronate metabolic process (GO:0019585) | 3.85625535 |
| 90 | regulation of plasminogen activation (GO:0010755) | 3.83232746 |
| 91 | regulation of bile acid biosynthetic process (GO:0070857) | 3.82008313 |
| 92 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.81100911 |
| 93 | regulation of humoral immune response (GO:0002920) | 3.80413976 |
| 94 | exogenous drug catabolic process (GO:0042738) | 3.78526117 |
| 95 | flavonoid metabolic process (GO:0009812) | 3.76925511 |
| 96 | organic acid catabolic process (GO:0016054) | 3.75656884 |
| 97 | carboxylic acid catabolic process (GO:0046395) | 3.75656884 |
| 98 | fibrinolysis (GO:0042730) | 3.72616103 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.72500104 |
| 100 | regulation of cholesterol homeostasis (GO:2000188) | 3.72459256 |
| 101 | acetyl-CoA metabolic process (GO:0006084) | 3.69764075 |
| 102 | complement activation, classical pathway (GO:0006958) | 3.68288696 |
| 103 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.68255505 |
| 104 | sterol homeostasis (GO:0055092) | 3.67914751 |
| 105 | ethanol metabolic process (GO:0006067) | 3.67134638 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 3.66521955 |
| 107 | phospholipid homeostasis (GO:0055091) | 3.66464110 |
| 108 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.66316606 |
| 109 | intestinal cholesterol absorption (GO:0030299) | 3.65508271 |
| 110 | aspartate family amino acid catabolic process (GO:0009068) | 3.65090217 |
| 111 | complement activation (GO:0006956) | 3.64246464 |
| 112 | intestinal absorption (GO:0050892) | 3.64000231 |
| 113 | plasma lipoprotein particle organization (GO:0071827) | 3.63801453 |
| 114 | protein-lipid complex assembly (GO:0065005) | 3.62001646 |
| 115 | diacylglycerol metabolic process (GO:0046339) | 3.61712310 |
| 116 | lipoprotein metabolic process (GO:0042157) | 3.61452499 |
| 117 | lipoprotein transport (GO:0042953) | 3.58812760 |
| 118 | cofactor catabolic process (GO:0051187) | 3.58030212 |
| 119 | negative regulation of lipase activity (GO:0060192) | 3.56936414 |
| 120 | carnitine metabolic process (GO:0009437) | 3.50485550 |
| 121 | fatty acid oxidation (GO:0019395) | 3.49217518 |
| 122 | negative regulation of blood coagulation (GO:0030195) | 3.46253870 |
| 123 | negative regulation of hemostasis (GO:1900047) | 3.46253870 |
| 124 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.40447658 |
| 125 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.40447658 |
| 126 | hormone catabolic process (GO:0042447) | 3.33034562 |
| 127 | negative regulation of protein activation cascade (GO:2000258) | 3.26714882 |
| 128 | positive regulation of hemostasis (GO:1900048) | 3.14416873 |
| 129 | positive regulation of blood coagulation (GO:0030194) | 3.14416873 |
| 130 | regulation of apoptotic cell clearance (GO:2000425) | 3.12019728 |
| 131 | alkaloid metabolic process (GO:0009820) | 3.12007066 |
| 132 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.11880008 |
| 133 | negative regulation of coagulation (GO:0050819) | 3.11001903 |
| 134 | phenylpropanoid metabolic process (GO:0009698) | 3.10311085 |
| 135 | acute inflammatory response (GO:0002526) | 3.06663592 |
| 136 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.05168609 |
| 137 | detection of bacterium (GO:0016045) | 3.03917473 |
| 138 | regulation of lipoprotein particle clearance (GO:0010984) | 3.01404294 |
| 139 | cytolysis (GO:0019835) | 3.01376781 |
| 140 | detection of other organism (GO:0098543) | 2.96181777 |
| 141 | negative regulation of wound healing (GO:0061045) | 2.94174630 |
| 142 | negative regulation of cell killing (GO:0031342) | 2.89384896 |
| 143 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89384896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.20047697 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.09785127 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.69352960 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.34668270 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.05517971 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.99974068 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.80784800 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.88426165 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.77642012 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.10391710 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.38422359 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.23185559 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04406304 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.04398638 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6651518 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91892863 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80363739 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.79837850 |
| 19 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.74539940 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.70502580 |
| 21 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.69452784 |
| 22 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58184096 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57842406 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57812642 |
| 25 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.55450736 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.50283395 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47094210 |
| 28 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.46462890 |
| 29 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46428480 |
| 30 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43650706 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42476586 |
| 32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41251788 |
| 33 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40838437 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.39979511 |
| 35 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.39705693 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36841775 |
| 37 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.35711570 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31480926 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30969900 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30448937 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30193781 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.29808012 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28986821 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28552544 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.26437659 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26252459 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.24545353 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24481808 |
| 49 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23839679 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22969811 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21609337 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21410696 |
| 53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.20908396 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19856751 |
| 55 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17984135 |
| 56 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16405368 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16163678 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.15665822 |
| 59 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15049544 |
| 60 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15033232 |
| 61 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.14616660 |
| 62 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14138565 |
| 63 | MYB_26560356_Chip-Seq_TH1_Human | 1.10941314 |
| 64 | P68_20966046_ChIP-Seq_HELA_Human | 1.08293471 |
| 65 | SA1_27219007_Chip-Seq_Bcells_Human | 1.08072568 |
| 66 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.07585432 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.06659141 |
| 68 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05687556 |
| 69 | P300_27268052_Chip-Seq_Bcells_Human | 1.04935092 |
| 70 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.03294666 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01732009 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01625119 |
| 73 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01405405 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01031267 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00827221 |
| 76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00757267 |
| 77 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99178712 |
| 78 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99134872 |
| 79 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97589449 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97153436 |
| 81 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97047064 |
| 82 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96664156 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95426690 |
| 84 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94853738 |
| 85 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93996378 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93931400 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 0.93702423 |
| 88 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93436118 |
| 89 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93123736 |
| 90 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91183746 |
| 91 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.90735746 |
| 92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90590481 |
| 93 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89914489 |
| 94 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.85992219 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85266301 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81659381 |
| 97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81570793 |
| 98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80354182 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.80046588 |
| 100 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79963949 |
| 101 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.77091741 |
| 102 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74755245 |
| 103 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.73495603 |
| 104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73418199 |
| 105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72537711 |
| 106 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72368109 |
| 107 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72001610 |
| 108 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71650089 |
| 109 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69983515 |
| 110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69578494 |
| 111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69430539 |
| 112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67251096 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67140050 |
| 114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.65945433 |
| 115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63700469 |
| 116 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63700469 |
| 117 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.63501092 |
| 118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.61956312 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60271797 |
| 120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60116087 |
| 121 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59767299 |
| 122 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59353036 |
| 123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.57421969 |
| 124 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.56655869 |
| 125 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56520357 |
| 126 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53803696 |
| 127 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53138096 |
| 128 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.52119786 |
| 129 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.52111690 |
| 130 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51611730 |
| 131 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.50619874 |
| 132 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.50510920 |
| 133 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50112766 |
| 134 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48498671 |
| 135 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48120674 |
| 136 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.47769600 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.47590329 |
| 138 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.47429333 |
| 139 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46059128 |
| 140 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.45626002 |
| 141 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.45454982 |
| 142 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44512065 |
| 143 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44229311 |
| 144 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.44015086 |
| 145 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43533281 |
| 146 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43061386 |
| 147 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.41842998 |
| 148 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.41112612 |
| 149 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41055434 |
| 150 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.40661186 |
| 151 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40267767 |
| 152 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40267127 |
| 153 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.39089391 |
| 154 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.39062436 |
| 155 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.38573950 |
| 156 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38400195 |
| 157 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.38299222 |
| 158 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.38275113 |
| 159 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37385644 |
| 160 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.37131228 |
| 161 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.37038491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.22832375 |
| 2 | MP0005360_urolithiasis | 8.05010740 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.15963983 |
| 4 | MP0005365_abnormal_bile_salt | 5.90246558 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.04793834 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.06649456 |
| 7 | MP0003252_abnormal_bile_duct | 3.86808582 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.47476472 |
| 9 | MP0009840_abnormal_foam_cell | 3.34964493 |
| 10 | MP0005332_abnormal_amino_acid | 3.03003465 |
| 11 | MP0003195_calcinosis | 2.82655284 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.79695564 |
| 13 | MP0005083_abnormal_biliary_tract | 2.73651142 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.52365781 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.38651008 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.17445042 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.09115674 |
| 18 | MP0000609_abnormal_liver_physiology | 2.05324402 |
| 19 | * MP0002118_abnormal_lipid_homeostasis | 2.02785519 |
| 20 | MP0002132_abnormal_respiratory_system | 1.92206727 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.82308683 |
| 22 | MP0003868_abnormal_feces_composition | 1.79445615 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.69708873 |
| 24 | MP0005025_abnormal_response_to | 1.68201323 |
| 25 | MP0003303_peritoneal_inflammation | 1.68181050 |
| 26 | MP0001764_abnormal_homeostasis | 1.65732424 |
| 27 | MP0009785_altered_susceptibility_to | 1.65620586 |
| 28 | MP0002419_abnormal_innate_immunity | 1.63149665 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.61135414 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59870248 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.55144944 |
| 32 | MP0005451_abnormal_body_composition | 1.53555456 |
| 33 | MP0000685_abnormal_immune_system | 1.46202662 |
| 34 | MP0005387_immune_system_phenotype | 1.44705261 |
| 35 | MP0001790_abnormal_immune_system | 1.44705261 |
| 36 | MP0009697_abnormal_copulation | 1.42838568 |
| 37 | MP0001800_abnormal_humoral_immune | 1.41046330 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.33536295 |
| 39 | MP0003186_abnormal_redox_activity | 1.31307189 |
| 40 | MP0005671_abnormal_response_to | 1.30069215 |
| 41 | MP0003866_abnormal_defecation | 1.26453807 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.25539449 |
| 43 | MP0003011_delayed_dark_adaptation | 1.24398759 |
| 44 | MP0002723_abnormal_immune_serum | 1.18938243 |
| 45 | MP0005636_abnormal_mineral_homeostasis | 1.16583843 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.15730677 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.12037203 |
| 48 | MP0000598_abnormal_liver_morphology | 1.10303804 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 1.08531958 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.05967774 |
| 51 | MP0009764_decreased_sensitivity_to | 1.05465212 |
| 52 | MP0000604_amyloidosis | 1.05396250 |
| 53 | MP0001819_abnormal_immune_cell | 1.04495590 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.04056051 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.03482764 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.03394827 |
| 57 | MP0005647_abnormal_sex_gland | 1.02550531 |
| 58 | MP0002254_reproductive_system_inflammat | 0.96928921 |
| 59 | MP0001986_abnormal_taste_sensitivity | 0.94408942 |
| 60 | MP0009763_increased_sensitivity_to | 0.91237391 |
| 61 | MP0005084_abnormal_gallbladder_morpholo | 0.90420414 |
| 62 | * MP0009642_abnormal_blood_homeostasis | 0.88317580 |
| 63 | MP0002876_abnormal_thyroid_physiology | 0.88243973 |
| 64 | MP0008469_abnormal_protein_level | 0.88115481 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 0.87481159 |
| 66 | MP0002405_respiratory_system_inflammati | 0.86234330 |
| 67 | MP0005670_abnormal_white_adipose | 0.85264279 |
| 68 | MP0001756_abnormal_urination | 0.83340006 |
| 69 | MP0004147_increased_porphyrin_level | 0.81994994 |
| 70 | MP0002396_abnormal_hematopoietic_system | 0.81864105 |
| 71 | MP0000716_abnormal_immune_system | 0.81028986 |
| 72 | MP0001545_abnormal_hematopoietic_system | 0.79845072 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 0.79845072 |
| 74 | MP0005408_hypopigmentation | 0.78251568 |
| 75 | MP0001663_abnormal_digestive_system | 0.78182713 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 0.77925964 |
| 77 | MP0005376_homeostasis/metabolism_phenot | 0.77675275 |
| 78 | MP0010368_abnormal_lymphatic_system | 0.77038421 |
| 79 | MP0005377_hearing/vestibular/ear_phenot | 0.76485650 |
| 80 | MP0003878_abnormal_ear_physiology | 0.76485650 |
| 81 | MP0003879_abnormal_hair_cell | 0.76240804 |
| 82 | MP0009379_abnormal_foot_pigmentation | 0.75897742 |
| 83 | MP0000858_altered_metastatic_potential | 0.75613471 |
| 84 | MP0008260_abnormal_autophagy | 0.75342738 |
| 85 | MP0004043_abnormal_pH_regulation | 0.75095120 |
| 86 | MP0005164_abnormal_response_to | 0.74811535 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.73575997 |
| 88 | * MP0002078_abnormal_glucose_homeostasis | 0.72481508 |
| 89 | * MP0000689_abnormal_spleen_morphology | 0.72228061 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.71026227 |
| 91 | MP0002398_abnormal_bone_marrow | 0.70753959 |
| 92 | MP0001851_eye_inflammation | 0.70124789 |
| 93 | MP0002971_abnormal_brown_adipose | 0.69929052 |
| 94 | MP0005535_abnormal_body_temperature | 0.69205521 |
| 95 | MP0005409_darkened_coat_color | 0.67572262 |
| 96 | MP0002166_altered_tumor_susceptibility | 0.67223193 |
| 97 | MP0003329_amyloid_beta_deposits | 0.67206102 |
| 98 | MP0003690_abnormal_glial_cell | 0.65532417 |
| 99 | MP0002822_catalepsy | 0.65435644 |
| 100 | * MP0002722_abnormal_immune_system | 0.64770421 |
| 101 | MP0002429_abnormal_blood_cell | 0.64551543 |
| 102 | MP0004947_skin_inflammation | 0.63850097 |
| 103 | MP0005266_abnormal_metabolism | 0.62841954 |
| 104 | MP0005220_abnormal_exocrine_pancreas | 0.62389323 |
| 105 | MP0009053_abnormal_anal_canal | 0.61676267 |
| 106 | MP0001661_extended_life_span | 0.60658846 |
| 107 | MP0004130_abnormal_muscle_cell | 0.57321855 |
| 108 | * MP0005334_abnormal_fat_pad | 0.56758856 |
| 109 | MP0005448_abnormal_energy_balance | 0.55980530 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.55372932 |
| 111 | MP0003638_abnormal_response/metabolism_ | 0.52686397 |
| 112 | MP0001765_abnormal_ion_homeostasis | 0.50802599 |
| 113 | MP0005395_other_phenotype | 0.49053625 |
| 114 | MP0005058_abnormal_lysosome_morphology | 0.48075291 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.47894379 |
| 116 | MP0000639_abnormal_adrenal_gland | 0.47342724 |
| 117 | MP0003718_maternal_effect | 0.45451094 |
| 118 | MP0005464_abnormal_platelet_physiology | 0.45318602 |
| 119 | MP0002796_impaired_skin_barrier | 0.44719926 |
| 120 | MP0005166_decreased_susceptibility_to | 0.44717125 |
| 121 | MP0003075_altered_response_to | 0.44404920 |
| 122 | MP0002928_abnormal_bile_duct | 0.44069131 |
| 123 | MP0004264_abnormal_extraembryonic_tissu | 0.43497974 |
| 124 | MP0008873_increased_physiological_sensi | 0.43039656 |
| 125 | MP0008872_abnormal_physiological_respon | 0.42884912 |
| 126 | MP0003724_increased_susceptibility_to | 0.42194382 |
| 127 | MP0004782_abnormal_surfactant_physiolog | 0.41641601 |
| 128 | MP0008874_decreased_physiological_sensi | 0.40816951 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.40377871 |
| 130 | * MP0003953_abnormal_hormone_level | 0.40211877 |
| 131 | MP0000538_abnormal_urinary_bladder | 0.36703067 |
| 132 | MP0003436_decreased_susceptibility_to | 0.34409975 |
| 133 | MP0005167_abnormal_blood-brain_barrier | 0.33703893 |
| 134 | MP0002168_other_aberrant_phenotype | 0.33514136 |
| 135 | MP0009672_abnormal_birth_weight | 0.32107124 |
| 136 | MP0009384_cardiac_valve_regurgitation | 0.31784267 |
| 137 | MP0005248_abnormal_Harderian_gland | 0.31709452 |
| 138 | MP0010234_abnormal_vibrissa_follicle | 0.31383520 |
| 139 | MP0001845_abnormal_inflammatory_respons | 0.30393365 |
| 140 | MP0006082_CNS_inflammation | 0.30385703 |
| 141 | MP0000249_abnormal_blood_vessel | 0.29892519 |
| 142 | MP0002837_dystrophic_cardiac_calcinosis | 0.29873944 |
| 143 | MP0002135_abnormal_kidney_morphology | 0.29268101 |
| 144 | MP0000579_abnormal_nail_morphology | 0.26954182 |
| 145 | MP0003300_gastrointestinal_ulcer | 0.26354784 |
| 146 | MP0004883_abnormal_blood_vessel | 0.25793986 |
| 147 | MP0001881_abnormal_mammary_gland | 0.25294764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.09099359 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.86402937 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.74628301 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.33647831 |
| 5 | Xanthomatosis (HP:0000991) | 6.06169237 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.04344119 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.91427925 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.22020650 |
| 9 | Complement deficiency (HP:0004431) | 4.75139351 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.73303570 |
| 11 | Hyperammonemia (HP:0001987) | 4.64812418 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.56905471 |
| 13 | Hyperglycinuria (HP:0003108) | 4.48369254 |
| 14 | Hyperglycinemia (HP:0002154) | 4.45904467 |
| 15 | Joint hemorrhage (HP:0005261) | 4.43427282 |
| 16 | Ketosis (HP:0001946) | 4.39556900 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.28833295 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 4.27882049 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.27882049 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.24905086 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.15071521 |
| 22 | Epidermoid cyst (HP:0200040) | 4.04511666 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 4.01225604 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 4.00192214 |
| 25 | Fat malabsorption (HP:0002630) | 3.98600336 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.94011684 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.85973077 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.65229924 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.59520439 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.55894003 |
| 31 | Myositis (HP:0100614) | 3.45561838 |
| 32 | Eczematoid dermatitis (HP:0000976) | 3.45384883 |
| 33 | Abnormality of complement system (HP:0005339) | 3.44180558 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.40815427 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.36933570 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.35479830 |
| 37 | Ketoacidosis (HP:0001993) | 3.34658076 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33478162 |
| 39 | Purpura (HP:0000979) | 3.31510464 |
| 40 | Orchitis (HP:0100796) | 3.27320449 |
| 41 | Hyperbilirubinemia (HP:0002904) | 3.23502060 |
| 42 | Delayed CNS myelination (HP:0002188) | 3.21335637 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 3.20604783 |
| 44 | Gout (HP:0001997) | 3.17243646 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 3.01327104 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 3.00334476 |
| 47 | Optic neuritis (HP:0100653) | 3.00334476 |
| 48 | Pulmonary embolism (HP:0002204) | 2.99347280 |
| 49 | Metabolic acidosis (HP:0001942) | 2.97796692 |
| 50 | Steatorrhea (HP:0002570) | 2.94288979 |
| 51 | Hepatocellular carcinoma (HP:0001402) | 2.86117201 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.85309132 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.85309132 |
| 54 | Vascular calcification (HP:0004934) | 2.78783763 |
| 55 | Epistaxis (HP:0000421) | 2.78699423 |
| 56 | Lethargy (HP:0001254) | 2.74908292 |
| 57 | Gastrointestinal infarctions (HP:0005244) | 2.74156390 |
| 58 | Spontaneous abortion (HP:0005268) | 2.73998566 |
| 59 | Malnutrition (HP:0004395) | 2.73155119 |
| 60 | Nephritis (HP:0000123) | 2.72616818 |
| 61 | Recurrent abscess formation (HP:0002722) | 2.71814351 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.70659809 |
| 63 | Myocardial infarction (HP:0001658) | 2.65728726 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.59066340 |
| 65 | Generalized aminoaciduria (HP:0002909) | 2.57990001 |
| 66 | Hypochromic microcytic anemia (HP:0004840) | 2.56998226 |
| 67 | Prolonged bleeding time (HP:0003010) | 2.47509899 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.46377006 |
| 69 | Gangrene (HP:0100758) | 2.45549065 |
| 70 | Joint swelling (HP:0001386) | 2.45235771 |
| 71 | Skin nodule (HP:0200036) | 2.44105865 |
| 72 | Irritability (HP:0000737) | 2.43111308 |
| 73 | Proximal tubulopathy (HP:0000114) | 2.42965829 |
| 74 | Abnormality of proline metabolism (HP:0010907) | 2.42120338 |
| 75 | Hydroxyprolinuria (HP:0003080) | 2.42120338 |
| 76 | Cerebral edema (HP:0002181) | 2.41421934 |
| 77 | Acanthocytosis (HP:0001927) | 2.40381896 |
| 78 | Spastic diplegia (HP:0001264) | 2.39969186 |
| 79 | Obstructive lung disease (HP:0006536) | 2.39457466 |
| 80 | Chronic obstructive pulmonary disease (HP:0006510) | 2.39457466 |
| 81 | Recurrent bacterial skin infections (HP:0005406) | 2.37539891 |
| 82 | Hypoglycemic seizures (HP:0002173) | 2.37318218 |
| 83 | Meningitis (HP:0001287) | 2.35783824 |
| 84 | Neonatal onset (HP:0003623) | 2.34878621 |
| 85 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.33650404 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.32998163 |
| 87 | Hypochromic anemia (HP:0001931) | 2.32474301 |
| 88 | Alkalosis (HP:0001948) | 2.31891284 |
| 89 | Late onset (HP:0003584) | 2.30548540 |
| 90 | Increased purine levels (HP:0004368) | 2.30168568 |
| 91 | Hyperuricemia (HP:0002149) | 2.30168568 |
| 92 | Vomiting (HP:0002013) | 2.29830490 |
| 93 | Widely patent fontanelles and sutures (HP:0004492) | 2.28778730 |
| 94 | Cholecystitis (HP:0001082) | 2.28240538 |
| 95 | Abnormal gallbladder physiology (HP:0012438) | 2.28240538 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 2.28077914 |
| 97 | Abnormal gallbladder morphology (HP:0012437) | 2.27690071 |
| 98 | Vasculitis (HP:0002633) | 2.26944141 |
| 99 | Anorexia (HP:0002039) | 2.25772786 |
| 100 | Increased serum ferritin (HP:0003281) | 2.25425673 |
| 101 | Enlarged kidneys (HP:0000105) | 2.24947629 |
| 102 | Cholelithiasis (HP:0001081) | 2.24038629 |
| 103 | Amyloidosis (HP:0011034) | 2.23189699 |
| 104 | Pancreatitis (HP:0001733) | 2.22361081 |
| 105 | Mitral stenosis (HP:0001718) | 2.22041291 |
| 106 | Encephalitis (HP:0002383) | 2.20303248 |
| 107 | Glycosuria (HP:0003076) | 2.20032221 |
| 108 | Abnormality of urine glucose concentration (HP:0011016) | 2.20032221 |
| 109 | Rickets (HP:0002748) | 2.18204908 |
| 110 | Glomerulonephritis (HP:0000099) | 2.16920759 |
| 111 | Pigmentary retinal degeneration (HP:0001146) | 2.14120471 |
| 112 | Keratoconjunctivitis sicca (HP:0001097) | 2.10226911 |
| 113 | Esophageal varix (HP:0002040) | 2.10209932 |
| 114 | Facial shape deformation (HP:0011334) | 2.07661539 |
| 115 | Potter facies (HP:0002009) | 2.07661539 |
| 116 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06641041 |
| 117 | Brushfield spots (HP:0001088) | 2.02685918 |
| 118 | Hypophosphatemia (HP:0002148) | 2.00307994 |
| 119 | Opisthotonus (HP:0002179) | 1.99900056 |
| 120 | Gingivitis (HP:0000230) | 1.99775866 |
| 121 | Recurrent skin infections (HP:0001581) | 1.99436862 |
| 122 | Menorrhagia (HP:0000132) | 1.97700443 |
| 123 | Keratoconjunctivitis (HP:0001096) | 1.97686626 |
| 124 | Osteomalacia (HP:0002749) | 1.97391490 |
| 125 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.97086608 |
| 126 | Arterial thrombosis (HP:0004420) | 1.95332515 |
| 127 | Gingival bleeding (HP:0000225) | 1.95017417 |
| 128 | Thrombophlebitis (HP:0004418) | 1.93903768 |
| 129 | Hypophosphatemic rickets (HP:0004912) | 1.93548714 |
| 130 | Abnormality of the gallbladder (HP:0005264) | 1.92369098 |
| 131 | Hemorrhage of the eye (HP:0011885) | 1.92030487 |
| 132 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.91295652 |
| 133 | Hyperphosphaturia (HP:0003109) | 1.91125887 |
| 134 | Abnormal cartilage morphology (HP:0002763) | 1.89007054 |
| 135 | Pulmonary infiltrates (HP:0002113) | 1.88708097 |
| 136 | Poikilocytosis (HP:0004447) | 1.87443936 |
| 137 | Abnormality of vitamin metabolism (HP:0100508) | 1.86812778 |
| 138 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86704155 |
| 139 | Confusion (HP:0001289) | 1.86542921 |
| 140 | Petechiae (HP:0000967) | 1.84622561 |
| 141 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.84088350 |
| 142 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84064555 |
| 143 | Recurrent fungal infections (HP:0002841) | 1.83462490 |
| 144 | Nausea (HP:0002018) | 1.83156059 |
| 145 | Skin rash (HP:0000988) | 1.82170349 |
| 146 | Pustule (HP:0200039) | 1.81592105 |
| 147 | Peritonitis (HP:0002586) | 1.81054984 |
| 148 | Mediastinal lymphadenopathy (HP:0100721) | 1.80815325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.15381776 |
| 2 | ERN1 | 4.50147412 |
| 3 | FGFR4 | 4.36576542 |
| 4 | SIK1 | 4.07694925 |
| 5 | MAP4K1 | 3.70983200 |
| 6 | RIPK4 | 3.50963922 |
| 7 | MST1R | 3.19507441 |
| 8 | TAOK3 | 2.82301088 |
| 9 | ERBB4 | 2.55601858 |
| 10 | INSRR | 2.53588279 |
| 11 | FES | 2.16601411 |
| 12 | ACVR1B | 2.05465591 |
| 13 | BLK | 1.98685036 |
| 14 | MAP2K4 | 1.98416136 |
| 15 | FRK | 1.86787804 |
| 16 | IRAK4 | 1.85602096 |
| 17 | PKN2 | 1.83029037 |
| 18 | MAPK11 | 1.82454918 |
| 19 | TNK2 | 1.76776599 |
| 20 | TRIB3 | 1.69935184 |
| 21 | ZAP70 | 1.68476635 |
| 22 | TXK | 1.63494364 |
| 23 | PTK6 | 1.62358180 |
| 24 | GRK6 | 1.62098522 |
| 25 | MATK | 1.61935335 |
| 26 | KIT | 1.57739308 |
| 27 | PIK3CG | 1.56346115 |
| 28 | SYK | 1.52435309 |
| 29 | FLT3 | 1.50960010 |
| 30 | TESK2 | 1.49497754 |
| 31 | FGR | 1.47245699 |
| 32 | TYK2 | 1.43947860 |
| 33 | ABL2 | 1.40976044 |
| 34 | PRPF4B | 1.40701161 |
| 35 | LATS1 | 1.40458586 |
| 36 | JAK3 | 1.35855378 |
| 37 | BTK | 1.32124331 |
| 38 | STK38L | 1.31856621 |
| 39 | WNK4 | 1.31551730 |
| 40 | MAP3K7 | 1.28029745 |
| 41 | DAPK2 | 1.24052209 |
| 42 | WNK3 | 1.23311257 |
| 43 | NEK9 | 1.21027105 |
| 44 | TBK1 | 1.18888806 |
| 45 | MET | 1.18622856 |
| 46 | LYN | 1.17193222 |
| 47 | PRKAA2 | 1.17086575 |
| 48 | KDR | 1.16282430 |
| 49 | PINK1 | 1.14156896 |
| 50 | LCK | 1.13248622 |
| 51 | JAK2 | 1.11328917 |
| 52 | ITK | 1.09156603 |
| 53 | TAOK1 | 1.09029194 |
| 54 | HCK | 1.03922850 |
| 55 | MAP2K3 | 0.97826671 |
| 56 | MAP3K14 | 0.96550616 |
| 57 | EPHB1 | 0.96508835 |
| 58 | MAP3K3 | 0.96157111 |
| 59 | FGFR2 | 0.93957435 |
| 60 | OXSR1 | 0.91958836 |
| 61 | MAP3K11 | 0.91583655 |
| 62 | ERBB2 | 0.91067011 |
| 63 | SIK2 | 0.90399224 |
| 64 | MAP3K10 | 0.87467531 |
| 65 | PRKCZ | 0.87410192 |
| 66 | IKBKB | 0.86940364 |
| 67 | MAPK4 | 0.86602886 |
| 68 | MAPK15 | 0.80497140 |
| 69 | TEC | 0.80305631 |
| 70 | RIPK1 | 0.79059244 |
| 71 | MAPK12 | 0.78945829 |
| 72 | JAK1 | 0.78665434 |
| 73 | DYRK1B | 0.78502888 |
| 74 | CDC42BPA | 0.78259648 |
| 75 | IRAK3 | 0.78194926 |
| 76 | PRKACG | 0.76417953 |
| 77 | MAP2K6 | 0.75638433 |
| 78 | TIE1 | 0.74844734 |
| 79 | SGK3 | 0.73046739 |
| 80 | GSK3A | 0.72523754 |
| 81 | PTK2 | 0.71345291 |
| 82 | PRKAA1 | 0.71140474 |
| 83 | PIK3CA | 0.69603216 |
| 84 | CDK12 | 0.68276451 |
| 85 | CSK | 0.67697295 |
| 86 | CAMK2G | 0.67461537 |
| 87 | MAP2K2 | 0.67310676 |
| 88 | NLK | 0.66772756 |
| 89 | CDK6 | 0.65432445 |
| 90 | PDPK1 | 0.62951828 |
| 91 | PDK3 | 0.61362130 |
| 92 | PDK4 | 0.61362130 |
| 93 | SGK223 | 0.61242908 |
| 94 | SGK494 | 0.61242908 |
| 95 | EPHA4 | 0.58073367 |
| 96 | MAP2K1 | 0.57369588 |
| 97 | MARK3 | 0.56926514 |
| 98 | BMPR2 | 0.55947856 |
| 99 | IKBKE | 0.55879734 |
| 100 | LRRK2 | 0.55589759 |
| 101 | SGK2 | 0.54391712 |
| 102 | EPHA3 | 0.53425006 |
| 103 | TGFBR2 | 0.52861590 |
| 104 | TAOK2 | 0.52161100 |
| 105 | FYN | 0.52018849 |
| 106 | MAP3K2 | 0.51784395 |
| 107 | PBK | 0.51577757 |
| 108 | YES1 | 0.50855102 |
| 109 | PIM1 | 0.49842646 |
| 110 | PRKCQ | 0.48764991 |
| 111 | IRAK1 | 0.47434768 |
| 112 | CAMK1D | 0.45271745 |
| 113 | HIPK2 | 0.44593138 |
| 114 | MAP3K6 | 0.43739139 |
| 115 | MARK2 | 0.42837715 |
| 116 | MAPK7 | 0.42310441 |
| 117 | GRK1 | 0.41396143 |
| 118 | IGF1R | 0.40387230 |
| 119 | MAP3K1 | 0.39480519 |
| 120 | PRKCD | 0.38571179 |
| 121 | PDK1 | 0.36703772 |
| 122 | FGFR3 | 0.36417609 |
| 123 | RPS6KC1 | 0.35741469 |
| 124 | RPS6KL1 | 0.35741469 |
| 125 | MAP3K5 | 0.35436342 |
| 126 | SMG1 | 0.33652715 |
| 127 | NEK1 | 0.33382882 |
| 128 | MAP3K13 | 0.32765582 |
| 129 | KSR2 | 0.32762457 |
| 130 | RET | 0.32295293 |
| 131 | PRKCA | 0.32074357 |
| 132 | CDK19 | 0.31941767 |
| 133 | PDK2 | 0.30994354 |
| 134 | CSNK1G1 | 0.30956511 |
| 135 | MAPKAPK2 | 0.30585657 |
| 136 | PRKCG | 0.30555312 |
| 137 | RPS6KA6 | 0.30498221 |
| 138 | BMX | 0.30271003 |
| 139 | CDK4 | 0.30028499 |
| 140 | CSF1R | 0.29131225 |
| 141 | ICK | 0.28848393 |
| 142 | PRKG2 | 0.28405160 |
| 143 | CAMK4 | 0.26094745 |
| 144 | EGFR | 0.25432340 |
| 145 | EPHB2 | 0.24355421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.21524293 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.43476399 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.30302626 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.16273552 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.92708149 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.71169844 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70290512 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62734939 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54235920 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.48754406 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.48066413 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.47863564 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.36995159 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.29149256 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.14373274 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10548258 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.02643739 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91690590 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90736488 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88648874 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87286838 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85226614 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82665383 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.82121467 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73645008 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68403934 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.66126056 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63417504 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62486465 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61531544 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61528858 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.61299331 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57206754 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51481127 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50859129 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50398767 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48522898 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39059605 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36840499 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.35043820 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33431627 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32067276 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31677702 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.30060034 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29720330 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25559866 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21043539 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19538120 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15540494 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13751684 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.12794457 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.12348519 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11482106 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06726940 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05099932 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.96658718 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94524514 |
| 58 | Allograft rejection_Homo sapiens_hsa05330 | 0.92605322 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92256761 |
| 60 | Leishmaniasis_Homo sapiens_hsa05140 | 0.89993492 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87456884 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.84176568 |
| 63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83330331 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82802190 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.82462410 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80696861 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79669606 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78293486 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.77257987 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68385062 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.65572265 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63243631 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62774008 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61476425 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59030588 |
| 76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58780566 |
| 77 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.53123159 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53073898 |
| 79 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.51395548 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.51330472 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50604743 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49041078 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43079859 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40184244 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.35297770 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32829620 |
| 87 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.31891339 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.26105941 |
| 89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.25599703 |
| 90 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.25152865 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24643054 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.19930053 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19296487 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18889423 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18446049 |
| 96 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.17689316 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17369034 |
| 98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.14903004 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.13353560 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.13321774 |
| 101 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.07211726 |
| 102 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05308795 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.04435119 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.01743560 |
| 105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2415254 |
| 106 | Lysosome_Homo sapiens_hsa04142 | -0.2345783 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | -0.2154700 |
| 108 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1968131 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1778825 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1698755 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1687772 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1666441 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | -0.1447968 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1360395 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1281398 |
| 116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1234019 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1103801 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1080214 |
| 119 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1038833 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0519924 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0487577 |
| 122 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0128283 |
| 123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0125405 |

